Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
8,314,673
-
Share change
-
+8,314,673
-
Total reported value
-
$162,073,973
-
Price per share
-
$19.73
-
Number of holders
-
28
-
Value change
-
+$162,074,012
-
Number of buys
-
28
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2018
As of 30 Jun 2018,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,314,673 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, FMR LLC, Fosun International Ltd, FIL Ltd, GILDER GAGNON HOWE & CO LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, CONNING INC., SPHERA FUNDS MANAGEMENT LTD., and Monashee Investment Management LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.